2020-00882. Meeting of the National Vaccine Advisory Committee

AGENCY:

Office of Infectious Disease and HIV/AIDS Policy, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services.

ACTION:

Notice.

SUMMARY:

As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) will hold a two-day meeting in-person meeting. The meeting will be open to the public and public comment sessions will be held during the meeting.

DATES:

The meeting will be held on Tuesday and Wednesday, February 13-14, 2020. The confirmed meeting times and agenda will be posted on the NVAC website at http://www.hhs.gov/​nvpo/​nvac/​meetings/​index.html as soon as they become available.

ADDRESSES:

Instructions regarding attending this meeting will be posted online at: http://www.hhs.gov/​nvpo/​nvac/​meetings/​index.html at least one week prior to the meeting. Pre-registration is required for those who wish to attend the meeting or participate in one of the public comment sessions. Please register at http://www.hhs.gov/​nvpo/​nvac/​meetings/​index.html.

FOR FURTHER INFORMATION CONTACT:

Ann Aikin, Acting Designated Federal Officer, at the Office of Infectious Disease and HIV/AIDS Policy, U.S. Department of Health and Human Services, Mary E. Switzer Building, Room L618, 330 C Street SW, Washington, DC 20024. Phone: [phone]; email: [e-mail].

SUPPLEMENTARY INFORMATION:

Pursuant to Section 2101 of the Public Health Service Act (42 U.S.C. 300aa-1), the Secretary of HHS was mandated to establish the National Vaccine Program to achieve optimal prevention of human infectious diseases through immunization and to achieve optimal prevention against adverse reactions to vaccines. The NVAC was established to provide advice and make recommendations to the Director of the National Vaccine Program on matters related to the Program's responsibilities. The Assistant Secretary for Health serves as Director of the National Vaccine Program.

During the February 2020 NVAC meeting, sessions will focus on vaccine innovation and vaccine confidence with updates from subcommittees and members. Please note that agenda items are related to charges of the committee and are subject to change, as priorities dictate. Information on the final meeting agenda will be posted prior to the meeting on the NVAC website: http://www.hhs.gov/​nvpo/​nvac/​index.html.

Members of the public will have the opportunity to provide comments at the NVAC meeting during the public comment periods designated on the agenda. Public comments made during the meeting will be limited to three minutes per person to ensure time is allotted for all those wishing to speak. Individuals are also welcome to submit written comments. Written comments should not exceed three pages in length. Individuals submitting written comments should email their comments to the National Vaccine Program Office ([e-mail]) at least five business days prior to the meeting.

Dated: January 3, 2020.

Ann Aikin,

Acting Designated Federal Official, Office of Infectious Disease and HIV/AIDS Policy.